Literature DB >> 20109482

Cardiomyocytes hypertrophic status after myocardial infarction determines distinct types of arrhythmia: role of the ryanodine receptor.

Jérémy Fauconnier1, Jean-Luc Pasquié, Patrice Bideaux, Alain Lacampagne, Sylvain Richard.   

Abstract

The mechanisms responsible for sudden cardiac death in heart failure (HF) are unclear. We investigated early and delayed afterdepolarizations (EADs, DADs) in HF. Cardiomyocytes were enzymatically isolated from the right ventricle (RV) and the septum of rats 8 weeks after myocardial infarction (MI) and sham-operated animals. Membrane capacitance, action potentials (AP) and ionic currents were measured by whole-cell patch-clamp. The [Ca(2+)](i) transients and Ca(2+) sparks were recorded with Fluo-4 during fluorescence measurements. Arrhythmia was triggered in 40% of MI cells (not in sham) using trains of 5 stimulations at 2.0 Hz. EADs and DADs occurred in distinct cell populations both in the RV and the septum. EADs occurred in normal-sized PMI cells (<230 pF), whereas DADs occurred in hypertrophic PMI cells (>230 pF). All cells exhibited prolonged APs due to reduced I(to) current. However, additional modifications in Ca(2+)-dependent ionic currents occurred in hypertrophic cells: a decrease in the inward rectifier K(+) current I(K1), and a slowing of L-type Ca(2+) current inactivation which was responsible for the lack of adaptation of APs to abrupt changes in the pacing rate. The occurrence of spontaneous Ca(2+) sparks, reflecting ryanodine receptor (RyR2) diastolic activity, increased with hypertrophy. The [Ca(2+)](i) transient amplitude, sarcoplasmic reticulum (SR) Ca(2+) load and Ca(2+) sparks amplitude were all inversely correlated with cell size. We conclude that the trophic status of cardiomyocytes determines the type of cellular arrhythmia in MI rats, based on differential electrophysiological remodeling which may reflect early-mild and late-severe or differential modifications in the RyR2 function. 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20109482     DOI: 10.1016/j.pbiomolbio.2010.01.002

Source DB:  PubMed          Journal:  Prog Biophys Mol Biol        ISSN: 0079-6107            Impact factor:   3.667


  5 in total

1.  Myofilament calcium de-sensitization and contractile uncoupling prevent pause-triggered ventricular tachycardia in mouse hearts with chronic myocardial infarction.

Authors:  Raghav Venkataraman; Marcelo Perim Baldo; Hyun Seok Hwang; Tiago Veltri; Jose Renato Pinto; Franz J Baudenbacher; Björn C Knollmann
Journal:  J Mol Cell Cardiol       Date:  2013-04-06       Impact factor: 5.000

2.  M3 subtype of muscarinic acetylcholine receptor promotes cardioprotection via the suppression of miR-376b-5p.

Authors:  Zhenyu Pan; Yueping Guo; Hanping Qi; Kai Fan; Shu Wang; Hua Zhao; Yuhua Fan; Jing Xie; Feng Guo; Yunlong Hou; Ning Wang; Rong Huo; Yong Zhang; Yan Liu; Zhimin Du
Journal:  PLoS One       Date:  2012-03-02       Impact factor: 3.240

3.  Trpm4 gene invalidation leads to cardiac hypertrophy and electrophysiological alterations.

Authors:  Marie Demion; Jérôme Thireau; Mélanie Gueffier; Amanda Finan; Ziad Khoueiry; Cécile Cassan; Nicolas Serafini; Franck Aimond; Mathieu Granier; Jean-Luc Pasquié; Pierre Launay; Sylvain Richard
Journal:  PLoS One       Date:  2014-12-22       Impact factor: 3.240

4.  Biodegradable Polymeric Nanocapsules Prevent Cardiotoxicity of Anti-Trypanosomal Lychnopholide.

Authors:  Renata Tupinambá Branquinho; Jérôme Roy; Charlotte Farah; Giani Martins Garcia; Franck Aimond; Jean-Yves Le Guennec; Dênia Antunes Saude-Guimarães; Andrea Grabe-Guimaraes; Vanessa Carla Furtado Mosqueira; Marta de Lana; Sylvain Richard
Journal:  Sci Rep       Date:  2017-03-28       Impact factor: 4.379

5.  Heat-shock transcription factor 1 is critically involved in the ischaemia-induced cardiac hypertrophy via JAK2/STAT3 pathway.

Authors:  Lingyan Yuan; Lin Qiu; Yong Ye; Jian Wu; Shuchun Wang; Xingxu Wang; Ning Zhou; Yunzeng Zou
Journal:  J Cell Mol Med       Date:  2018-07-11       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.